We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-5.36%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$1.57B
AUM Growth
-$188M
Cap. Flow
-$40.2M
Cap. Flow %
-2.55%
Top 10 Hldgs %
25.73%
Holding
273
New
11
Increased
56
Reduced
164
Closed
13

Sector Composition

Rank Sector Weight
1 Healthcare 27.91%
2 Technology 24.74%
3 Industrials 19.75%
4 Consumer Discretionary 7.88%
5 Communication Services 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFIN icon
1
Donnelley Financial Solutions
DFIN
$1.21B
$56.4M 3.58%
1,001,579
-67,977
-6% -$3.3M
LRN icon
2
Stride
LRN
$3.48B
$50.7M 3.22%
1,126,442
-20,139
-2% -$819K
WNS
3
DELISTED
WNS Holdings
WNS
$49.6M 3.15%
724,193
+46,968
+7% +$3.17M
DOOR
4
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$45.3M 2.88%
486,154
-9,460
-2% -$951K
TKO icon
5
TKO Group
TKO
$13.5B
$37.8M 2.4%
+449,630
New +$41.7M
ARLO icon
6
Arlo Technologies
ARLO
$1.59B
$36.9M 2.35%
3,585,940
-111,564
-3% -$1.18M
ACIW icon
7
ACI Worldwide
ACIW
$5.81B
$33.2M 2.11%
1,470,148
-32,511
-2% -$760K
MEDP icon
8
Medpace
MEDP
$16B
$32M 2.03%
132,087
-9,328
-7% -$2.39M
PBH icon
9
Prestige Consumer Healthcare
PBH
$2.35B
$31.7M 2.01%
554,190
-9,480
-2% -$573K
EEFT icon
10
Euronet Worldwide
EEFT
$2.77B
$31.5M 2%
397,449
-12,216
-3% -$1.13M
PCRX icon
11
Pacira BioSciences
PCRX
$1.04B
$29.7M 1.89%
968,485
+61,680
+7% +$2.22M
ZD icon
12
Ziff Davis
ZD
$1.92B
$27.6M 1.75%
432,789
-9,528
-2% -$654K
AGM icon
13
Federal Agricultural Mortgage
AGM
$2.38B
$26.5M 1.69%
172,032
-13,792
-7% -$2.23M
AX icon
14
Axos Financial
AX
$5.69B
$22.7M 1.44%
599,822
-11,342
-2% -$480K
XPO icon
15
XPO
XPO
$23.6B
$22.7M 1.44%
303,539
-6,669
-2% -$460K
FC icon
16
Franklin Covey
FC
$236M
$21.9M 1.39%
509,698
+28,434
+6% +$1.26M
NGVT icon
17
Ingevity
NGVT
$2.48B
$19.5M 1.24%
410,033
+42,408
+12% +$2.31M
ESTA icon
18
Establishment Labs
ESTA
$2.72B
$18.1M 1.15%
368,407
+107,441
+41% +$6.42M
LCII icon
19
LCI Industries
LCII
$2.46B
$17.8M 1.13%
151,659
-57,119
-27% -$7.16M
PGTI
20
DELISTED
PGT, Inc.
PGTI
$17.5M 1.11%
631,214
-10,706
-2% -$295K
AWI icon
21
Armstrong World Industries
AWI
$7.31B
$17.3M 1.1%
240,537
-5,263
-2% -$393K
LGND icon
22
Ligand Pharmaceuticals
LGND
$5.84B
$17M 1.08%
282,961
-5,198
-2% -$342K
BCRX icon
23
BioCryst Pharmaceuticals
BCRX
$2.29B
$16.1M 1.02%
2,275,638
+402,674
+21% +$2.89M
RDWR icon
24
Radware
RDWR
$1.07B
$16.1M 1.02%
951,807
-16,829
-2% -$296K
DOCS icon
25
Doximity
DOCS
$3.75B
$16.1M 1.02%
757,286
-16,491
-2% -$450K

Similar funds

Rice Hall James & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Rice Hall James & Associates held 273 positions worth $1.57B, down 11% from $1.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rice Hall James & Associates's Q3 2023 filing shows 11 new, 56 increased, 164 reduced and 13 closed positions. Its largest new stake was TKO Group: 449,630 shares worth $37.8M. The largest sale was World Wrestling Entertainment, an estimated $51.6M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Industrials.

  • Rice Hall James & Associates's largest Q3 2023 buy was TKO Group: 449,630 shares worth $37.8M.
  • Rice Hall James & Associates added most to Establishment Labs in Q3 2023, an estimated $6.42M increase.
  • Rice Hall James & Associates's biggest Q3 2023 reduction was Qualys, cutting an estimated $7.98M.
  • Rice Hall James & Associates fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $51.6M.
  • Rice Hall James & Associates's ten largest holdings make up 26% of its $1.57B portfolio in Q3 2023.
  • Rice Hall James & Associates opened 11 new positions and closed 13 in Q3 2023.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $1.57B.

Based on Rice Hall James & Associates's 13F filing for Q3 2023, filed 2 Nov 2023.